Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:1061-1062
Published online before print April 8, 2004, doi: 10.1161/01.STR.0000126476.10473.47
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/5/1061    most recent
01.STR.0000126476.10473.47v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leys, D.
Right arrow Articles by Pasquier, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leys, D.
Right arrow Articles by Pasquier, F.
Related Collections
Right arrow Clinical genetics
Right arrow Other hypertension
Right arrow Clinical Studies
Right arrow Epidemiology

(Stroke. 2004;35:1061.)
© 2004 American Heart Association, Inc.


Original Contributions

Editorial Comment—Not All Hypertensive Subjects Have Similar Risks for White Matter Lesions: Influence of Genetic Factors

Didier Leys, MD, PhD Florence Pasquier, MD, PhD

Stroke and Memory Departments, Hôpital Roger Salengro, Lille, France


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

White matter lesions (WML) are frequently found on magnetic resonance imaging (MRI) scans in stroke patients, in patients with cognitive decline or dementia, and in healthy—usually elderly—subjects who have vascular risk factors, especially arterial hypertension.1 However, many neurologists in their clinical practice have seen elderly subjects with a long history of improperly treated arterial hypertension who have only few WML. They have met also middle-aged subjects, with less severe, more recent, and properly treated arterial hypertension with already extensive WML. These clinical findings suggest that not all hypertensive subjects have similar risks of WML.

Genetic factors may explain differences in the susceptibility of the cerebral white matter to arterial hypertension: (1) cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is clearly identified as a genetic disease due to a mutation in the Notch 3 gene, in which severe WML occur at an early stage of the disease in young subjects, even in the absence of vascular risk factors;2 (2) other genetic disorders may also lead to severe WML in the absence of vascular factors, eg, CARASIL (the R indicating recessive) and other nonNotch type angiopathies,3 familial amyloid angiopathies,4 hereditary endotheliopathy with retinopathy nephropathy and stroke,5 and cerebroretinal angiopathies;6 and (3) a greater correlation between the volumes of WML is observed between monozygotic twins than between dizygotic twins.7

Among the various genes that potentially predispose to WML in the presence of arterial hypertension, the apolipoprotein E (APOE) gene is one of the best candidates: (1) the APOE which is . . . [Full Text of this Article]